These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1657259)

  • 1. Low molecular weight heparin.
    Gough S
    BMJ; 1991 Sep; 303(6805):784. PubMed ID: 1657259
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
    Breyer HG
    Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of post-operative thrombosis by low molecular weight heparin in patients undergoing hip replacement.
    Thomas DP
    Thromb Haemost; 1992 May; 67(5):491-3. PubMed ID: 1325677
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 5. Major orthopaedic surgery and post-discharge DVT.
    ten Cate JW; Prins MH
    Lancet; 1996 Jul; 348(9022):209-10. PubMed ID: 8684194
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J
    Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830
    [No Abstract]   [Full Text] [Related]  

  • 7. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the prevention of venous thromboembolic disease in orthopaedics: the introduction of LMWH.
    Colwell CW; Paiement G; Pellegrini VD; Salvati EA; Stulberg BN
    Contemp Orthop; 1993 Dec; 27(6):551-77. PubMed ID: 10146586
    [No Abstract]   [Full Text] [Related]  

  • 10. DVT prophylaxis in total hip replacement.
    DeLoughery TG
    J Gen Intern Med; 1993 Nov; 8(11):641-2. PubMed ID: 8289108
    [No Abstract]   [Full Text] [Related]  

  • 11. Enoxaparin--a low-molecular-weight heparin.
    Med Lett Drugs Ther; 1993 Aug; 35(903):75-6. PubMed ID: 8393510
    [No Abstract]   [Full Text] [Related]  

  • 12. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparins and prevention of postoperative thrombosis.
    Bounameaux H
    Br J Surg; 1989 May; 76(5):524. PubMed ID: 2544244
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
    Hauch O; Khattar SC; Jørgensen LN
    Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement.
    Mätzsch T; Bergqvist D; Fredin H; Hedner U
    Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management.
    Horlocker TT; Heit JA
    Anesth Analg; 1997 Oct; 85(4):874-85. PubMed ID: 9322474
    [No Abstract]   [Full Text] [Related]  

  • 17. Deep venous thrombosis: low-molecular-weight heparins in perioperative prophylaxis.
    Merli G
    Cleve Clin J Med; 1995; 62(6):368-9. PubMed ID: 8556807
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.
    Turpie AG
    Br J Clin Pract Suppl; 1989 Jan; 65():18-23; discussion 23-5. PubMed ID: 2554949
    [No Abstract]   [Full Text] [Related]  

  • 19. Postoperative deep venous thrombosis (DVT) and low-molecular weight heparin (LMWH) type and dosage.
    Wicky J; Couson F; Ambrosetti P; Didier D; Rohner A; Bounameaux H
    Thromb Haemost; 1993 Apr; 69(4):402-3. PubMed ID: 8388582
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement.
    Mätzsch T; Bergqvist D; Fredin H; Hedner U
    Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.